Abbvie Inc Cdr Stock Today
| ABBV Stock | 27.02 0.49 1.85% |
Performance0 of 100
| Odds Of DistressLess than 9
|
AbbVie is trading at 27.02 as of the 28th of November 2024, a 1.85% increase since the beginning of the trading day. The stock's lowest day price was 26.5. AbbVie has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AbbVie Inc CDR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
AbbVie is entity of Canada. It is traded as Stock on NEO exchange. The company has 16.7 B outstanding shares. More on AbbVie Inc CDR
Moving against AbbVie Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AbbVie Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | Richard Gonzalez |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-General, Healthcare (View all Sectors) |
AbbVie Inc CDR (ABBV) is traded on NEO Exchange in Canada and employs 50,000 people. AbbVie is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 451.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc CDR operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.7 B outstanding shares.
Check AbbVie Probability Of Bankruptcy
AbbVie Inc CDR Risk Profiles
Although AbbVie's alpha and beta are two of the key measurements used to evaluate AbbVie's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.05 | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.25 | |||
| Risk Adjusted Performance | (0.02) |
AbbVie Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
AbbVie Corporate Management
Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sanjay Narayan | Chief SVP | Profile | |
| Assil Omar | VP Officer | Profile | |
| Tracie Haas | Brand Responsibility | Profile | |
| Roopal MD | Executive Officer | Profile | |
| Greg Miley | Senior Affairs | Profile |
Other Information on Investing in AbbVie Stock
AbbVie financial ratios help investors to determine whether AbbVie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbbVie with respect to the benefits of owning AbbVie security.